Zentiva Set To Acquire Romania's Solacium
Executive Summary
Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.
You may also be interested in...
Czech Republic's Zentiva Snaps Up Alvogen’s CEE Operations
Acquiring Alvogen’s operations in central and eastern Europe will strengthen private equity-backed Zentiva’s presence in both the OTC and generics markets.
Romania’s OTC Market in 2018: Colds And Flu Epidemic Help Boost Sales By 14%
Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018.
Alvogen Settles With Celgene Over US Revlimid
Alvogen can sell in the US generic lenalidomide on a volume-limited basis after March 2022, and without volume limitations in early 2026, after settling patent litigation with Celgene relating to the originator’s Revlimid. Dr Reddy's has also settled in Canada.